Text
Gut microbes contribute to symptoms associated with neurological conditions. New microbe-inspired therapies could be develop to treat such conditions.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
Executive Director George Paraskevakos presents the role of the International Probiotics Association (IPA) at this year’s Probiotics, Prebiotics & New Foods conference, to be held in September in Rome.
Microbial transplants could be used as a non-invasive and safe strategy to manipulate the gut microbiota, which has been linked to HIV infection.
Common gut fungi called Debaryomyces hansenii can influence the severity of Crohn’s disease and other inflammatory bowel diseases.
Microbial and fungal communities interactions shape the gut microbiota in preterm babies. The findings could help to develop microbiota interventions.
The alterations in gut microbial composition could play a role in the gastrointestinal complications associated with Parkinson’s disease.
A bacterial strain, called Staphylococcus hominis A9, inhibited the expression of a S. aureus toxin that promotes inflammation in atopic dermatitis.
The gut microbiota make-up could determine whether a person will benefit from the beneficial effects of the Mediterranean diet.
Probiotics such as Lactobacillus and Bifidobacterium can activate a person’s immune system and improve the response to some anti-cancer therapies.
